Home > CPGs > Thyroid Dysfunction > Guidelines and Tools
   
PDA Formats
How are CPGs
created?
Subscribe for CPGs
 
Investigation and Management of Primary Thyroid Dysfunction
PUBLISHED: 2006

REVISED:March 2008

TOPIC: Thyroid

SCOPE: Testing for suspected hypo or
hyper thyroidism, TSH use in thyroxine
therapy for treatment of hypothyroidism
or monitoring thyroxine therapy in thyroid
cancer, pregnancy, and in patients
receiving lithium or amiodarone

    ABSTRACT: 
    This full text guideline replaces previous thyroid guidelines produced by the AMA and addresses testing and monitoring of patients with suspected hypo or hyperthyroidism.

    TARGET POPULATION: 

    EXCLUSIONS: 
    • Neonatal patients,
    • TSH is NOT reliable in cases of suspected pituitary disease. FT4 is recommended
    • TSH may be an unreliable indicator of thyroid status in patients with severe nonthyroidal illness (e.g., CCU, ICU, acute severe psychiatric illness)
    • TSH may not reflect the clinical status within 3 months of therapy for hyperthyroidism with radioactive iodine. During this time FT4 is recommended
    • Thyroxine suppression  therapy is NOT recommended for thyroid nodules or euthyroid nodular goiter

    Summary: Thyroid Dysfunction
     
    Guideline: Thyroid Dysfunction
     
    Patient Information: Thyroid Dysfunction
     

     

     
    		 
    Working Group Membership
    A multi-disciplinary team comprised of:

    Family Physicians
    Laboatory Specialists
    Endocrinologists